Bruton's Tyrosine Kinase Inhibition in Pemphigus: An Embattled Frontier

J Invest Dermatol. 2024 Aug;144(8):1667-1670. doi: 10.1016/j.jid.2024.03.014. Epub 2024 Apr 29.

Authors

Aimee S Payne¹, Silvio Manfredo Vieira²

Affiliations

¹ Department of Dermatology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA. Electronic address: [email protected].
² Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

PMID: 38691069
DOI: 10.1016/j.jid.2024.03.014

No abstract available

Publication types

Letter

MeSH terms

Agammaglobulinaemia Tyrosine Kinase* / antagonists & inhibitors
Humans
Pemphigus* / drug therapy
Protein Kinase Inhibitors* / pharmacology
Protein Kinase Inhibitors* / therapeutic use
Protein-Tyrosine Kinases / antagonists & inhibitors
Protein-Tyrosine Kinases / metabolism

Substances

Agammaglobulinaemia Tyrosine Kinase
Protein Kinase Inhibitors
BTK protein, human
Protein-Tyrosine Kinases